• Marco Chiado’ Piat

    Terumo Pharmaceutical Solutions

    Episode 32

    Marathons. Wine. And 30 years in healthcare.

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Marco Chiado’ Piat, President, at Terumo Pharmaceutical Solutions part of Terumo. Marco has worked in the pharma and healthcare sector since the early 1990s. His impressive experience has included eight years at McKinsey before he

    Read more
  • Jim Miller

    CDMO expert and speaker

    Episode 31

    The industry guru

    In this one hour special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Jim Miller. If you’ve worked in the bio and pharmaceutical CDMO space for a few years, then there’s a very good chance you will know my guest today. Jim is a renowned

    Read more
  • Raman Sehgal

    Host of Molecule to Market

    Episode 30

    10 Trends for 2021

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with… Raman Sehgal, founder of ramarketing and the Molecule to Market podcast. Your host, Raman shares ten trends that he expects to see in 2021 and beyond based on themes from podcast interviews and expert insights

    Read more
  • Tia Lyles-Williams

    LucasPye Bio

    Episode 29

    The CDMO disrupter

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tia Lyles-Williams, CEO of LucasPye Bio. Tia is the first African-American Queer Woman to own & lead a Biopharma Large-Scale Manufacturing Company in the US. She has spent 20 years in the industry formerly working

    Read more
  • Roger Lias

    Stelis Biopharma

    Episode 28

    The biologic CDMO growth guy

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Roger Lias, Chief Executive Officer at Stelis Biopharma. A fellow-Brit, Roger is a graduate of the University of Southampton. He also holds a PhD in Biotechnology from the University of Cambridge. His experience of the

    Read more
  • Mark Quick

    Recipharm

    Episode 27

    Leading M&A at a top-5 global CDMO

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark Quick, Executive Vice President, Corporate Development at Recipharm. In the decade that Mark and Raman have known each other, Mark has risen from a BD role in a small Swedish CMO, to becoming one

    Read more
  • Tom Hochuli & Stefan Beyer

    Vibalogics

    Episode 26

    The virotherapy virtuoso

    In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Stefan Beyer, President and Managing Director at Vibalogics and Tom Hochuli, Chief Executive Officer at Vibalogics. Who is this dynamic duo you ask? Stefan has spent the bulk of his career in the vaccines and

    Read more
  • ramarketing roundtables

    Episode 25

    Roundtable: Collaboration and driving efficiency

    In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host  Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Dexter Tjoa, Chief Executive Officer at Tjoapack, Erik Haeffler, VP Manufacturing Services & Head of Sustainability at Recipharm AB, John Ross, President at Mayne Pharma and Metrics

    Read more
  • ramarketing roundtables

    Episode 24

    Roundtable: Latest trends in CDMO

    In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host  Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Roger Lias Chief Executive Officer at Stelis Biopharma Pvt. Ltd. and Stelis Biopharma LLC, Mark Quick, Executive Vice President Corporate Development at Recipharm AB, Lynn

    Read more
  • ramarketing roundtables

    Episode 23

    Roundtable: Clinical trials in 2020 and beyond

    In this special episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with host  Raman Sehgal, Founder & Global President at ramarketing, Laura Child, CRO Sector Lead at ramarketing, Torkel Gren, Senior Director, Technology Officer & Strategic Investments at Recipharm, Sascha Sonnenberg, Global Head of Business Development at Sharp Clinical Services, Vincent Dunne, CEO

    Read more